Status:
UNKNOWN
Comparison of the 'CTR' Ratio With Standard Haemostasis Parameters in the Follow-up of Patients Undergoing Heparin Therapy
Lead Sponsor:
Direction Centrale du Service de Santé des Armées
Conditions:
Venous Thromboembolic Disease
Eligibility:
All Genders
18-65 years
Brief Summary
The Quantra(r) hemostasis analyzer (Stago) is a recent addition to the family of global hemostasis tests. It uses ultrasound-based technology to characterize the viscoelastic properties of a whole blo...
Eligibility Criteria
Inclusion
- Patients over 18 and affiliated to the french social security system
- Patients on curative heparin (low molecular weight heparin or non-fractionated heparin) for whom anti-Xa activity is prescribed or planned by the clinician
- Samples taken between working hours
- No opposition to study participation
Exclusion
- Patients unable to consent
- Anti-Xa activity not prescribed
- Patients on another anticoagulant treatment or not anticoagulated about it
- Samples taken during non-working hours
- Pregnant or breast-feeding women
- Insufficient language level for understanding the information note
Key Trial Info
Start Date :
June 22 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05993533
Start Date
June 22 2023
End Date
December 31 2023
Last Update
August 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
HIA Bégin
Saint-Mandé, France, 94160